Autologous Umbilical Cord Blood Infusion followed by Oral Docosahexaenoic Acid and Vitamin D Supplementation for C-Peptide Preservation in Children with Type 1 Diabetes

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 7, 2013, Pages 1126-1129

  Haller, Michael J ^a   Wasserfall, Clive H ^b   Hulme, Maigan A ^b   Cintron, Miriam ^a   Brusko, Todd M ^b   McGrail, Keiran M ^b   Wingard, John R ^a   Theriaque, Douglas W ^b   Shuster, Jonathan J ^b   Ferguson, Ronald J ^b   Kozuch, Marianne ^c   Clare Salzler, Michael ^b   Atkinson, Mark A ^b   Schatz, Desmond A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c University of Florida   (United States)

Author keywords

Autologous cord blood; C Peptide; Docosahexaenoic acid; Type 1 diabetes; Vitamin D

Indexed keywords

AUTOANTIBODY; C PEPTIDE; DOCOSAHEXAENOIC ACID; INSULIN; VITAMIN D;

ANTIBODY TITER; ARTICLE; AUTOLOGOUS UMBILICAL CORD BLOOD; AUTOTRANSPLANTATION; CD4 LYMPHOCYTE COUNT; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OPEN STUDY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; VITAMIN SUPPLEMENTATION;

ADMINISTRATION, ORAL; AREA UNDER CURVE; C-PEPTIDE; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; DIABETES MELLITUS, TYPE 1; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, AUTOLOGOUS; VITAMIN D;

EID: 84879395767     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.04.011     Document Type: Article

References (10)

1. Haller M.J., Wasserfall C.H., Hulme M.A., et al. Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide. Diabetes Care 2011, 34:2567-2569.
2. Haller M.J., Wasserfall C.H., McGrail K.M., et al. Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care 2009, 32:2041-2046.
3. Haller M.J., Viener H.L., Wasserfall C., et al. Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol 2008, 36:710-715.
4. Driscoll K.A., Johnson S.B., Schatz D.A., et al. Use of a precious resource: Parental decision making about using autologous umbilical cord blood in studies involving young children with type 1 diabetes. Contemp Clin Trials 2011, 32:524-529.
5. Antico A., Tampoia M., Tozzoli R., et al. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev 2012, 12:127-136.
6. Miller M.R., Seifert J., Szabo N.J., et al. Erythrocyte membrane fatty acid content in infants consuming formulas supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA): An observational study. Matern Child Nutr 2010, 6:338-346.
7. Bligh E.G., Dyer W.J. Arapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
8. Maxwell R.J., Marmer W.N. Systematic protocol for the accumulation of fatty acid data from multiple tissue samples: Tissue handling, lipid extraction and class separation, and capillary gas chromatographic analysis. Lipids 1983, 18:453-459.
9. Schneider A., Rieck M., Sanda S., et al. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells. JImmunol 2008, 181:7350-7355.
10. Parker M.J., Xue S., Alexander J.J., et al. Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice. Diabetes 2009, 58:2277-2284.